Nexalin Technology, Inc.

Contributing Author

Recent Articles by Nexalin Technology, Inc.

Oct-21	Nexalin's DIFS Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer's and Dementia Across Three Peer-Reviewed Studies NXL GlobeNewswire
Oct-13	Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer's and Traumatic Brain Injury Programs NXL GlobeNewswire
Oct-10	Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit NXL GlobeNewswire
Oct-08	Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer's Disease with Gen-2 SYNC Neurostimulation Device NXL GlobeNewswire
Sep-25	Nexalin Technology Announces Issuance of U.S. Patent Covering HALO Clarity Device Featuring DIFS Technology NXL GlobeNewswire
Aug-25	Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on September 9 NXL GlobeNewswire
Aug-01	Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives NXL GlobeNewswire
May-28	Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3 NXL GlobeNewswire
May-13	Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data NXL GlobeNewswire
May-06	Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering NXL GlobeNewswire
May-05	Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock NXL GlobeNewswire
May-01	Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback NXL GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.